wan tai seet, mohd asyraf mat afandi, mohamad fikeri ishak, muhammad najib fathi hassan, nazeha ahmat, min hwei ng and manira maarof. (2023). quality management overview for the production of a tissue-engineered human skin substitute in malaysia. - stem cell research & therapy. 1-14.
shamsul sulaiman, rizal abdul rani, nor hamdan mohamad yahaya, yasuhiko tabata, yosuke hiraoka, wan tai seet, min hwei ng. (2022). physical and natural crosslinking approaches on three-dimensional gelatin microspheres for cartilage regeneration. - tissue engineering part c. 557-569.
wan tai seet, mohd asyraf mat afandi, sharen aini shamsuddin, yogeswaran lokanathan, min hwei ng, manira maarof. (2022). stem cell production - processes, practices and regulations. - . 32.
wan tai seet, mohd asyraf mat afandi, mohamad fikeri ishak, muhammad najib fathi hassan, nazeha ahmat, min hwei ng and manira maarof. (2023). quality management overview for the production of a tissue-engineered human skin substitute in malaysia. - stem cell research & therapy. 1-14.
shamsul sulaiman, rizal abdul rani, nor hamdan mohamad yahaya, yasuhiko tabata, yosuke hiraoka, wan tai seet, min hwei ng. (2022). physical and natural crosslinking approaches on three-dimensional gelatin microspheres for cartilage regeneration. - tissue engineering part c. 557-569.
wan tai seet, mohd asyraf mat afandi, mohamad fikeri ishak, muhammad najib fathi hassan, nazeha ahmat, min hwei ng and manira maarof. (2023). quality management overview for the production of a tissue-engineered human skin substitute in malaysia. - stem cell research & therapy. 1-14.
shamsul sulaiman, rizal abdul rani, nor hamdan mohamad yahaya, yasuhiko tabata, yosuke hiraoka, wan tai seet, min hwei ng. (2022). physical and natural crosslinking approaches on three-dimensional gelatin microspheres for cartilage regeneration. - tissue engineering part c. 557-569.
wan tai seet, mohd asyraf mat afandi, sharen aini shamsuddin, yogeswaran lokanathan, min hwei ng, manira maarof. (2022). stem cell production - processes, practices and regulations. - . 32.